| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
TESK2 |
TESK2: Dual specificity testis-specific protein kinase 2 |
2.622 |
Evidence |
|
| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-38 alpha chain precursor |
2.622 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
NULL |
IPI00383408 |
2.622 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
HLA-C |
HLA-C, D6S204, HLA-JY3, HLAC: HLA class I histocompatibility antigen, Cw-17 alph |
2.622 |
Evidence |
|
| KCNA5 |
KCNA5: Potassium voltage-gated channel subfamily A member 5 |
KCND3 |
KCND3: Potassium voltage-gated channel subfamily D member 3 |
2.622 |
Evidence |
|
| NULL |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-33 alpha chain precursor |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
MXD1 |
MXD1, MAD: MAD protein |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
NHLH1 |
NHLH1, HEN1: Helix-loop-helix protein 1 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
2.622 |
Evidence |
|
| KCNE1 |
KCNE1: Potassium voltage-gated channel subfamily E member 1 |
KCNQ1 |
KCNQ1, KCNA8, KCNA9, KVLQT1: Potassium voltage-gated channel subfamily KQT membe |
2.622 |
Evidence |
|
| GABRA1 |
GABRA1: Gamma-aminobutyric acid receptor subunit alpha-1 precursor |
GABRA4 |
GABRA4: Gamma-aminobutyric acid receptor subunit alpha-4 precursor |
2.622 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-G |
HLA-G, DAQB-346J13.1-002, DASS-366B6.2-002, XXbac-BCX209H21.15-002, XXbac-BPG12I |
2.622 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-DQA1 |
IPI00736570 |
2.622 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-81 alpha chain precursor |
2.622 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
NULL |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-67 alpha chain precursor |
2.622 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
TCF3 |
IPI00216911 |
2.622 |
Evidence |
|
| LYL1 |
LYL1: Protein lyl-1 |
TCF3 |
IPI00216911 |
2.622 |
Evidence |
|
| ELA3B |
ELA3B: Elastase-3B precursor |
SERPINB11 |
SERPINB11: Serpin B11 |
2.622 |
Evidence |
|
| FES |
FES, FPS: Proto-oncogene tyrosine-protein kinase Fes/Fps |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
2.622 |
Evidence |
|
| FES |
FES, FPS: Proto-oncogene tyrosine-protein kinase Fes/Fps |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
2.622 |
Evidence |
|
| HLA-DQA1 |
HLA class II histocompatibility antigen, DQ(W3) alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
2.622 |
Evidence |
|